Erratum: CD147 subunit of lactate/H+ symporters MCT1 and hypoxia-inducible MCT4 is critical for energetics and growth of glycolytic tumors (Proceedings of the National Academy of Sciences of the United States of America (2011) 108, 40 (16663-16668) DOI: 10.1073/pnas.1106123108);CD147 subunit of lactate/H+ symporters MCT1 and hypoxia-inducible MCT4 is critical for energetics and growth of glycolytic tumors

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 40, 2011, Pages 16663-16668

  Le Floch, Renaud ^a   Chiche, Johanna ^a   Marchiq, Ibtissam ^a   Naïken, Tanesha ^a   Ilk, Karine ^a   Murray, Clare M ^b   Critchlow, Susan E ^b   Roux, Danièle ^a   Simon, Marie Pierre ^a   Pouysségur, Jacques ^a  

^a CNRS   (France)

^b ASTRAZENECA   (United Kingdom)

Author keywords

Cancer metabolism; Embigin; EMMPRIN; Lactate transport; Warburg effect

Indexed keywords

CD147 ANTIGEN; LACTIC ACID; MONOCARBOXYLATE TRANSPORTER 1; MONOCARBOXYLATE TRANSPORTER 2; MONOCARBOXYLATE TRANSPORTER 4; SHORT HAIRPIN RNA;

ARTICLE; CARCINOGENESIS; CARCINOMA CELL; COLON ADENOCARCINOMA; ENERGY TRANSFER; FIBROBLAST; GENE SILENCING; GLYCOLYSIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH;

EID: 80053640489     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1219161109     Document Type: Erratum

References (45)

1. Gatenby RA, Gillies RJ (2008) A microenvironmental model of carcinogenesis. Nat Rev Cancer 8:56-61.
2. Kroemer G, Pouyssegur J (2008) Tumor cell metabolism: Cancer's Achilles' heel. Cancer Cell 13:472-482. (Pubitemid 351766797)
3. Vander Heiden MG, Cantley LC, Thompson CB (2009) Understanding the Warburg effect: The metabolic requirements of cell proliferation. Science 324:1029-1033.
4. Kaelin WG, Jr., Thompson CB (2010) Q&A: Cancer: Clues from cell metabolism. Nature 465:562-564.
5. Semenza GL (2010) HIF-1: Upstream and downstream of cancer metabolism. Curr Opin Genet Dev 20:51-56.
6. Tennant DA, Durán RV, Gottlieb E (2010) Targeting metabolic transformation for cancer therapy. Nat Rev Cancer 10:267-277.
7. Tudzarova S, et al. (2011) Two ubiquitin ligases, APC/C-Cdh1 and SKP1-CUL1-F (SCF)-beta-TrCP, sequentially regulate glycolysis during the cell cycle. Proc Natl Acad Sci USA 108:5278-5283.
8. Pouysségur J, Dayan F, Mazure NM (2006) Hypoxia signalling in cancer and approaches to enforce tumour regression. Nature 441:437-443. (Pubitemid 44050138)
9. Brahimi-Horn MC, Bellot G, Pouysségur J (2011) Hypoxia and energetic tumour metabolism. Curr Opin Genet Dev 21:67-72.
10. Thiery JP, Acloque H, Huang RY, Nieto MA (2009) Epithelial-mesenchymal transitions in development and disease. Cell 139:871-890.
11. Fantin VR, St-Pierre J, Leder P (2006) Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. Cancer Cell 9: 425-434. (Pubitemid 43832190)
12. Christofk HR, et al. (2008) The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature 452:230-233. (Pubitemid 351380249)
13. Spoden GA, et al. (2008) Isotype-specific inhibitors of the glycolytic key regulator pyruvate kinase subtype M2 moderately decelerate tumor cell proliferation. Int J Cancer 123:312-321. (Pubitemid 351842015)
14. Sonveaux P, et al. (2008) Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice. J Clin Invest 118:3930-3942.
15. Le A, et al. (2010) Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression. Proc Natl Acad Sci USA 107:2037-2042.
16. Pouyssegur J, Franchi A, Pages G (2001) pHi, aerobic glycolysis and vascular endothelial growth factor in tumour growth. Novartis Found Symp 240:186-196, and discussion 196-198.
17. L'Allemain G, Paris S, Pouysségur J (1984) Growth factor action and intracellular pH regulation in fibroblasts. Evidence for a major role of the Na+/H+ antiport. J Biol Chem 259:5809-5815. (Pubitemid 14145050)
18. Counillon L, Pouysségur J (2000) The expanding family of eucaryotic Na(+)/H(+) exchangers. J Biol Chem 275:1-4. (Pubitemid 30038944)
19. Chiche J, et al. (2009) Hypoxia-inducible carbonic anhydrase IX and XII promote tumor cell growth by counteracting acidosis through the regulation of the intracellular pH. Cancer Res 69:358-368.
20. Ullah MS, Davies AJ, Halestrap AP (2006) The plasma membrane lactate transporter MCT4, but not MCT1, is up-regulated by hypoxia through a HIF-1alpha-dependent mechanism. J Biol Chem 281:9030-9037. (Pubitemid 43864615)
21. Chiche J, Le Floch R, Roux D, Pouysségur J (2008) The monocarboxylate transporter 1 (MCT1) and Hypoxia-induced MCT4 are key targets promoting tumor cell surviva. Eur J Cancer, Suppl 6:24.
22. Halestrap AP, Meredith D (2004) The SLC16 gene family-from monocarboxylate transporters (MCTs) to aromatic amino acid transporters and beyond. Pflugers Arch 447:619-628. (Pubitemid 38241446)
23. Kirk P, et al. (2000) CD147 is tightly associated with lactate transporters MCT1 and MCT4 and facilitates their cell surface expression. EMBO J 19:3896-3904. (Pubitemid 30608530)
24. Weidle UH, Scheuer W, Eggle D, Klostermann S, Stockinger H (2010) Cancer-related issues of CD147. Cancer Genomics Proteomics 7:157-169.
25. Kennedy KM, Dewhirst MW (2010) Tumor metabolism of lactate: The influence and therapeutic potential for MCT and CD147 regulation. Future Oncol 6:127-148.
26. Biswas C, et al. (1995) The human tumor cell-derived collagenase stimulatory factor (renamed EMMPRIN) is a member of the immunoglobulin superfamily. Cancer Res 55: 434-439.
27. Igakura T, et al. (1998) A null mutation in basigin, an immunoglobulin superfamily member, indicates its important roles in peri-implantation development and spermatogenesis. Dev Biol 194:152-165. (Pubitemid 28117579)
28. Murray CM, et al. (2005) Monocarboxylate transporter MCT1 is a target for immunosuppression. Nat Chem Biol 1:371-376.
29. Pouysségur J, Franchi A, Salomon JC, Silvestre P (1980) Isolation of a Chinese hamster fibroblast mutant defective in hexose transport and aerobic glycolysis: Its use to dissect the malignant phenotype. Proc Natl Acad Sci USA 77:2698-2701. (Pubitemid 10057902)
30. Franchi A, Silvestre P, Pouysségur J (1981) A genetic approach to the role of energy metabolism in the growth of tumor cells: Tumorigenicity of fibroblast mutants deficient either in glycolysis or in respiration. Int J Cancer 27:819-827. (Pubitemid 11125620)
31. Ovens MJ, Davies AJ, Wilson MC, Murray CM, Halestrap AP (2010) AR-C155858 is a potent inhibitor of monocarboxylate transporters MCT1 and MCT2 that binds to an intracellular site involving transmembrane helices 7-10. Biochem J 425:523-530.
32. Schneiderhan W, et al. (2009) CD147 silencing inhibits lactate transport and reduces malignant potential of pancreatic cancer cells in in vivo and in vitro models. Gut 58: 1391-1398.
33. Santiago Y, et al. (2008) Targeted gene knockout in mammalian cells by using engineered zinc-finger nucleases. Proc Natl Acad Sci USA 105:5809-5814. (Pubitemid 351758454)
34. Wilson MC, Meredith D, Bunnun C, Sessions RB, Halestrap AP (2009) Studies on the DIDS-binding site of monocarboxylate transporter 1 suggest a homology model of the open conformation and a plausible translocation cycle. J Biol Chem 284: 20011-20021.
35. Lain E, et al. (2009) A novel role for embigin to promote sprouting of motor nerve terminals at the neuromuscular junction. J Biol Chem 284:8930-8939.
36. Pouysségur J, Sardet C, Franchi A, L'Allemain G, Paris S (1984) A specific mutation abolishing Na+/H+ antiport activity in hamster fibroblasts precludes growth at neutral and acidic pH. Proc Natl Acad Sci USA 81:4833-4837. (Pubitemid 14066209)
37. Pastorekova S, Kopacek J, Pastorek J (2007) Carbonic anhydrase inhibitors and the management of cancer. Curr Top Med Chem 7:865-878. (Pubitemid 46830331)
38. Swietach P, et al. (2008) Tumor-associated carbonic anhydrase 9 spatially coordinates intracellular pH in three-dimensional multicellular growths. J Biol Chem 283: 20473-20483.
39. Lou Y, et al. (2011) Targeting tumor hypoxia: Suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors. Cancer Res 71:3364-3376, correction (2011) 71:4733.
40. Chiche J, et al. (2011) In vivo pH in metabolic-defective Ras-transformed fibroblast tumors: Key role of the monocarboxylate transporter, MCT4, for inducing an alkaline intracellular pH. Int J Cancer, in press 10.1002/ijc.26125.
41. Manning Fox JE, Meredith D, Halestrap AP (2000) Characterisation of human monocarboxylate transporter 4 substantiates its role in lactic acid efflux from skeletal muscle. J Physiol 529:285-293. (Pubitemid 32040847)
42. Dimmer KS, Friedrich B, Lang F, Deitmer JW, Bröer S (2000) The low-affinity monocarboxylate transporter MCT4 is adapted to the export of lactate in highly glycolytic cells. Biochem J 350:219-227.
43. Gallagher SM, Castorino JJ, Wang D, Philp NJ (2007) Monocarboxylate transporter 4 regulates maturation and trafficking of CD147 to the plasma membrane in the metastatic breast cancer cell line MDA-MB-231. Cancer Res 67:4182-4189. (Pubitemid 46815064)
44. Gallagher SM, Castorino JJ, Philp NJ (2009) Interaction of monocarboxylate transporter 4 with beta1-integrin and its role in cell migration. Am J Physiol Cell Physiol 296:C414-C421.
45. Stock C, Schwab A (2006) Role of the Na/H exchanger NHE1 in cell migration. Acta Physiol (Oxf) 187:149-157. (Pubitemid 43828772)